Geneos Wealth Management’s Stantec STN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,950
Closed -$255K 2532
2026
Q1
$255K Hold
2,950
0.01% 884
2025
Q4
$278K Buy
+2,950
New +$304K 0.01% 822
2021
Q2
Sell
-42
Closed -$1K 3098
2021
Q1
$1K Hold
42
﹤0.01% 3063
2020
Q4
$1K Buy
+42
New +$1.29K ﹤0.01% 2832

Other funds holding STN

Geneos Wealth Management's STN Position: Q2 2026 in Review

Geneos Wealth Management sold out of Stantec (STN) in Q2 2026, closing a stake of 2,950 shares — an estimated $255K sold.

Geneos Wealth Management first reported a position in STN in Q4 2020 and held it in 4 quarters. The position peaked at $278K in Q4 2025. 290 funds tracked by Wall St. Rank hold STN as of Q2 2026.

  • Geneos Wealth Management reported no remaining Stantec position as of Q2 2026 after selling out during the quarter.
  • Geneos Wealth Management sold 2,950 Stantec shares in Q2 2026, an estimated $255K.
  • Geneos Wealth Management first reported a position in Stantec in Q4 2020 and held it in 4 quarters.
  • Geneos Wealth Management's Stantec position peaked at $278K in Q4 2025.
  • 290 funds tracked by Wall St. Rank held Stantec as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.